LIVE PRESS CONFERENCE: Union World Conference on Lung Health : M72 Vaccine study primary results presented
The primary results from the M72/AS01E candidate vaccine study were announced during a press conference held at the Union World Conference on Lung Health.
Professor Mark Hatherill, SATVI Director presented the results from the clinical research.
Chair: Paula Fujiwara, Scientific Director, International Union Against Tuberculosis and Lung Disease (The Union)
Thomas Ottenhoff, Co-Chair, TB Science 2018, Time to talk about a TB vaccine
Marie-Ange Demoitie, Glaxo -Smith Kline, M72 Prevention of disease trial- preliminary results
Mark Hatherill, SAVTI, Impact of Recent vaccine results - the way forward
Ann Ginsberg, IAVI, Next steps towards a TB vaccine
Lucica Ditiu, Executive Director, STOP TB Partnership, A community perspective
Click here to view.